semaglutide side effects bad taste in mouth Why do I have a funny my while on Wegovy? Research published today might leave

Clinical applications of astaxanthin in the treatment of ocular diseases: Emerging insights

However, these drugs come with a significant out-of-pocket cost

[18] The Endocrine Society's position statement on GH secretagogues notes: "Ghrelin receptor agonists, including ipamorelin, represent a pharmacologically rational approach to physiologic GH stimulation, but their use outside approved indications requires careful patient selection and monitoring given the absence of large-scale safety data." [1] The American Association of Clinical Endocrinology (AACE) has similarly called for outcome-based surveillance registries for patients receiving compounded peptide therapies, recognizing that real-world safety data collection is the primary tool available in the absence of phase III trials

The discontinuation was driven by (Bergam, 2025) (Figure 2): the availability of newer, safer & more accurate alternative testing for MG including electrophysiological & antibody tests, as well as safety concerns (bradycardia & respiratory complications) limited diagnostic reliability (with both false-positive and false-negative results) The decision to remove edrophonium as an available (alternative) diagnostic test has been challenged (Keritam et al, 2026)